166 related articles for article (PubMed ID: 22191414)
1. Novel therapies for glaucoma: a patent review 2007 - 2011.
Carta F; Supuran CT; Scozzafava A
Expert Opin Ther Pat; 2012 Jan; 22(1):79-88. PubMed ID: 22191414
[TBL] [Abstract][Full Text] [Related]
2. Antiglaucoma carbonic anhydrase inhibitors: a patent review.
Masini E; Carta F; Scozzafava A; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):705-16. PubMed ID: 23627893
[TBL] [Abstract][Full Text] [Related]
3. Sulfonamides: a patent review (2008 - 2012).
Carta F; Scozzafava A; Supuran CT
Expert Opin Ther Pat; 2012 Jul; 22(7):747-58. PubMed ID: 22697257
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013-2019).
Nocentini A; Supuran CT
Expert Opin Ther Pat; 2019 Oct; 29(10):805-815. PubMed ID: 31486689
[No Abstract] [Full Text] [Related]
5. Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018).
Angeli A; Supuran CT
Expert Opin Ther Pat; 2019 Oct; 29(10):793-803. PubMed ID: 31462124
[No Abstract] [Full Text] [Related]
6. Treatment of glaucoma and ocular hypertension using rho kinase inhibitors: patent evaluation of US2018244666 and US2018256595.
Bonardi A; Supuran CT
Expert Opin Ther Pat; 2019 Oct; 29(10):753-759. PubMed ID: 31438732
[No Abstract] [Full Text] [Related]
7. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).
Carta F; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):681-91. PubMed ID: 23488823
[TBL] [Abstract][Full Text] [Related]
8. Antiglaucoma medications: a review of safety and tolerability issues related to their use.
Schuman JS
Clin Ther; 2000 Feb; 22(2):167-208. PubMed ID: 10743979
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019.
Supuran CT; Altamimi ASA; Carta F
Expert Opin Ther Pat; 2019 Oct; 29(10):781-792. PubMed ID: 31596641
[No Abstract] [Full Text] [Related]
10. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
Aggarwal M; McKenna R
Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994
[TBL] [Abstract][Full Text] [Related]
11. Topical therapies for glaucoma: what family physicians need to know.
Lewis PR; Phillips TG; Sassani JW
Am Fam Physician; 1999 Apr; 59(7):1871-9, 1882. PubMed ID: 10208706
[TBL] [Abstract][Full Text] [Related]
12. Anti-infective carbonic anhydrase inhibitors: a patent and literature review.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):693-704. PubMed ID: 23488877
[TBL] [Abstract][Full Text] [Related]
13. Novel therapies for glaucoma: a patent review (2013-2019).
Guglielmi P; Carradori S; Campestre C; Poce G
Expert Opin Ther Pat; 2019 Oct; 29(10):769-780. PubMed ID: 31385719
[No Abstract] [Full Text] [Related]
14. Rho-kinase inhibitors in the management of glaucoma.
Berrino E; Supuran CT
Expert Opin Ther Pat; 2019 Oct; 29(10):817-827. PubMed ID: 31573364
[No Abstract] [Full Text] [Related]
15. Advances in the discovery of novel agents for the treatment of glaucoma.
Mincione F; Nocentini A; Supuran CT
Expert Opin Drug Discov; 2021 Oct; 16(10):1209-1225. PubMed ID: 33914670
[TBL] [Abstract][Full Text] [Related]
16. A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma.
Long DD; Frieman B; Hegde SS; Hill CM; Jiang L; Kintz S; Marquess DG; Purkey H; Shaw JP; Steinfeld T; Wilson MS; Wrench K
Bioorg Med Chem Lett; 2013 Feb; 23(4):939-43. PubMed ID: 23317571
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties.
Di Fiore A; Scozzafava A; Winum JY; Montero JL; Pedone C; Supuran CT; De Simone G
Bioorg Med Chem Lett; 2007 Mar; 17(6):1726-31. PubMed ID: 17251017
[TBL] [Abstract][Full Text] [Related]
18. Rho kinase inhibitors: a patent review (2012 - 2013).
Feng Y; LoGrasso PV
Expert Opin Ther Pat; 2014 Mar; 24(3):295-307. PubMed ID: 24283930
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009.
Poulsen SA
Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848
[TBL] [Abstract][Full Text] [Related]
20. Antiobesity carbonic anhydrase inhibitors: a literature and patent review.
Scozzafava A; Supuran CT; Carta F
Expert Opin Ther Pat; 2013; 23(6):725-35. PubMed ID: 23607332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
